Irish building materials giant CRH has reported a robust second-quarter performance, underscored by solid demand, strong pricing dynamics, and a strategic focus on high-value acquisitions.
Revenues for Q2 2025 rose by 6% year-on-year to $10.2bn, with net income up 2% to $1.3bn.
Adjusted EBITDA increased by 9% to $2.5bn, driving margins higher by 70 basis points to 24.1%.
Diluted earnings per share rose to $1.94, up 3% on the prior year.
The group’s positive results reflect CRH’s proven strategy and the strength of its integrated portfolio, which continues to deliver value through market cycles.
Commenting on the results, Chief Executive Officer Jim Mintern said: "Our strong second quarter performance was driven by favorable underlying demand, disciplined commercial management and further contributions from acquisitions.
“CRH's proven strategy continued to drive higher sales, profits and Adjusted EBITDA margins, while our robust balance sheet and financial capacity enabled us to allocate approximately $3bn to growth investments and capital returns year-to-date.
“We completed 19 acquisitions year-to-date and continue to see an active pipeline of opportunities to further strengthen our market-leading positions in attractive growth markets.
“Underlying demand in our key end-use markets remains positive and we are pleased to raise our guidance for 2025."
CRH has invested $1bn across 19 acquisitions so far this year, reinforcing its position in strategic growth areas.
Among the standout deals is the $2.1bn acquisition of Eco Material Technologies, a move set to accelerate CRH’s cementitious growth strategy.
The company continues to return capital to shareholders, with $0.8bn in share buybacks completed year-to-date.
A new $0.3bn tranche has now been launched. CRH has also declared a 6% year-on-year increase in its quarterly dividend to $0.37 per share.
Looking ahead, the group is confident in continued positive activity across its key end-use markets.
It has raised full-year 2025 guidance, now expecting net income between $3.8bn and $3.9bn and Adjusted EBITDA in the range of $7.5bn to $7.7bn.
With a strong balance sheet, active M&A pipeline, and favourable market conditions, CRH remains well-positioned to sustain its growth trajectory through 2025 and beyond.
